WASHINGTON – A COVID-19 vaccine that could soon win U.S. approval may offer a boost for the U.S. military: an opportunity to get shots into some...
GENEVA – The World Health Organization said Thursday that it has granted an emergency use authorization for the coronavirus vaccine made by China’s CanSino Biologics, the...
Pfizer is spending more than $11.6 billion to buy the remaining portion of migraine treatment maker Biohaven Pharmaceuticals it does not already own. The New York...
Pfizer on Friday said a large trial found that its COVID-19 oral antiviral treatment Paxlovid was not effective at preventing coronavirus infection in people living with...
WASHINGTON — U.S. President Joe Biden is set to receive a second booster dose of the Pfizer COVID-19 vaccine on Wednesday, the White House announced, a...
CAMBRIDGE, MASS. — Moderna has begun testing an Omicron-specific COVID-19 booster in healthy adults. The company announced Wednesday that the first participant had received a dose....
Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded on Wednesday the prestigious Genesis Prize for his efforts in leading the...
Health Canada has authorized the use of Pfizer’s COVID-19 antiviral treatment Paxlovid, the first oral and at-home prescription medication to be cleared for use in this...
A Toronto hospital executive is calling on Health Canada to approve Pfizer’s COVID-19 antiviral pill amid increasing hospitalizations the country. Dr. Kevin Smith, who is president...
Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn’t appear...
The Palestinian Health Ministry on Thursday said it has identified its first three cases of the Omicron variant of the coronavirus in the occupied West Bank....